https://www.selleckchem.com/products/gw788388.html
Subgroups were unrelated to clinical characteristics, except for functional status. The modified PCOQ showed evidence of construct validity. Patients considered low symptom severity to be acceptable, irrespective of the symptom. Findings suggest that symptom severity and importance are related yet distinct aspects of the advanced lung cancer symptom experience. Patients have heterogeneous priorities for symptom improvement, which has implications for tailoring treatment. The modified PCOQ showed evidence of construct validity. Patients
Like
Comment
Share
